TRAF6 Activation in Multiple Myeloma: A Potential Therapeutic Target

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2012.01.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

CD26 Is a Potential Therapeutic Target by Humanized Monoclonal Antibody for the Treatment of Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2018English

The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma

Oncotarget
Oncology
2017English

EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

A DNA Repair Pathway Score Predicts Survival in Human Multiple Myeloma: The Potential for Therapeutic Strategy

Oncotarget
Oncology
2014English

TAMs Are a Potential Therapeutic Target in Glioma

Cancer Discovery
Oncology
2013English

Adipose ABCG1: A Potential Therapeutic Target in Obesity?

Adipocyte
HistologyCell Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy